UnknownNot Applicable

Discordance in the Evaluation of Suicidal Intent Between Parents and Adolescents in Adolescence and Evolution of the Suicidal Crisis : a Mixed Study

France160 participantsStarted 2023-07-27

Plain-language summary

The goal of this mixed-methods study is to describe the association between the level of parent/adolescent discordance in the assessment of the adolescent's level of suicidal intentionality after a suicid attempt and the evolution of the suicidal crisis by assessing the evolution of the adolescent's suicidal intentionality between T0 and 3 months. The main questions it aims to answer are: * To show the association between the level of parent/adolescent discordance in the assessment of the adolescent's level of suicidal intent after a suicid attempt and various markers of the evolution of the suicidal crisis at 3 months. * Explore the experience of adolescents and their parents regarding the elements they consider relevant in assessing the adolescent's suicidal intent. Participants will be asked to complete various self- and hetero-questionnaires at T0 and T3

Who can participate

Age range

11 Years – 17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adolescents: * aged 11 to 17 * admitted to a pediatric or adult emergency department following a suicide attempt * proficient in spoken French * not opposed to participation in the research * accompanied by at least one parent who is not opposed to the adolescent's participation in the research. * Parents: * 18 years of age or older * parent or guardian of an adolescent admitted to a pediatric or adult emergency department following a suicide attempt * fluent in spoken French * not opposed to participation in the research Exclusion Criteria: * present a decompensated somatic or psychiatric pathology or a vigilance disorder * refusal to participate in the research

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Difference in adolescents' level of suicidal intent

Timeframe: 3 months

Trial details

NCT IDNCT06036290

SponsorUniversity Hospital, Clermont-Ferrand

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-05-27

Contact for this trial

Lise Laclautre

0 promo_interne_drci@chu-clermontferrand.fr

View on ClinicalTrials.gov More Suicidal Intention trials